SNWV · XBRL financial data

SANUWAVE Health financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (SNWV's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	4,057	13,010	16,742	20,398	32,634	44,051
Revenue from contracts with customers	4,057	11,383	15,511	19,255	32,331	—
Cost of revenue	1,162	4,986	4,331	6,035	8,084	10,082
Gross profit	2,895	8,024	12,411	14,363	24,550	33,969
Research and development	1,246	1,101	567	579	673	1,353
General and administrative	13,724	11,690	12,556	8,674	11,348	19,372
Total operating expenses	28,095	22,166	21,363	14,903	19,133	29,024
Operating income (loss)	(25,200)	(14,142)	(8,952)	(540)	5,417	4,945
Interest expense	2,025	6,883	12,771	—	12,565	—
Other income (expense)	(5,737)	(13,089)	(1,339)	(25,263)	(36,762)	6,954
Income tax expense (benefit)	0	28	2	4	27	86
Net income (loss)	(30,937)	(27,259)	(10,293)	(25,807)	(31,372)	11,813
Earnings per share, basic‡ USD per share	(29.63)	(18.52)	(7.41)	(11.11)	(7.03)	1.38
Earnings per share, diluted‡ USD per share	(29.63)	(18.52)	(7.41)	(11.11)	(7.03)	0.41
Weighted average shares, basic‡ thousands of shares	1,021	1,400	1,484	2,143	4,463	8,564
Weighted average shares, diluted‡ thousands of shares	1,021	1,400	1,484	2,143	4,463	9,083

‡ Per-share figures and share counts are adjusted for the 1-for-370.3703703703703 stock split (October 2024); filings made before it reported them unadjusted.
† Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (SNWV's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	2,437	619	1,153	1,797	10,237	11,959
Accounts receivable	2,355	2,415	4,029	3,314	3,329	5,422
Inventory	2,956	1,040	868	2,951	4,149	5,934
Prepaid and other current assets	179	326	570	1,722	682	1,312
Total current assets	7,928	4,400	6,620	9,784	18,397	24,627
Property and equipment, net	471	668	750	938	732	1,972
Right-of-use asset	725	151	—	—	429	390
Goodwill	7,260	7,260	7,260	7,260	7,260	7,260
Total assets	23,028	18,619	19,873	22,416	30,119	37,343
Accounts payable	4,454	7,644	4,400	5,705	3,728	3,251
Accrued liabilities	2,127	4,394	8,512	5,999	4,678	8,382
Current portion of long-term debt	16,593	25,387	—	—	—	5,750
Total current liabilities	36,174	56,263	60,187	64,755	42,345	17,847
Long-term debt	143	875	—	—	—	16,142
Lease liability, non-current	158	74	—	—	—	—
Total liabilities	36,746	57,577	60,883	65,594	42,836	35,724
Accumulated deficit	(156,690)	(183,949)	(194,242)	(220,049)	(251,421)	(242,685)
Total stockholders' equity	(13,719)	(38,958)	(41,010)	(43,178)	(12,717)	1,619
Total liabilities and equity	23,028	18,619	19,873	22,416	30,119	37,343
Common shares outstanding (cover page)‡ thousands of shares	1,300	1,396	1,508	3,080	8,548	8,594

‡ Per-share figures and share counts are adjusted for the 1-for-370.3703703703703 stock split (October 2024); filings made before it reported them unadjusted.
† Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (SNWV's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(30,937)	(27,259)	(10,293)	(25,807)	(31,372)	11,813
Stock-based compensation	22	0	—	0	1,514	4,850
Depreciation and amortization	299	532	952	1,028	1,145	974
Net cash from operating activities	(12,718)	(6,409)	(17,169)	(4,538)	2,455	3,876
Purchases of property and equipment	53	529	—	0	490	1,942
Net cash from investing activities	(20,053)	(529)	332	21	(490)	3,433
Proceeds from issuing common stock	—	—	—	0	10,300	0
Net cash from financing activities	33,448	5,121	17,384	5,211	6,354	(5,587)
Net change in cash	677	(1,818)	534	644	8,440	1,722

† Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
SANUWAVE Health	9,376	9,739	425*	8.6M	—	Q2 FY26 10-QJun 30, 2026
Cerus	16,350	57,714	3,007*	202.0M	—	Q3 FY26 10-QSep 30, 2026
Electromed	20,450	19,417*	2,994*	8.4M	—	Q4 FY26 10-KJun 30, 2026
Tactile Systems Technology	75,110	91,858	11,978*	22.4M	—	Q3 FY26 10-QSep 30, 2026
Orasure Technologies	160,582	30,639	(9,921)*	69.0M	16.2 quarters	Q2 FY26 10-QJun 30, 2026
Bioventus	30,709	142,442	20,658*	not reported	—	Q3 FY26 10-QSep 26, 2026
Treace Medical Concepts	12,610	45,376	(4,698)*	65.0M	9.7 quarters	Q2 FY26 10-QJun 30, 2026
SS Innovations International	13,647	not reported	(4,235)*	200.4M	3.2 quarters	Q2 FY26 10-QJun 30, 2026
Inogen	87,276	95,084	2,946*	26.5M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.